This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ZIOPHARM Oncology Inc (ZIOP)


Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 42.80M 68.20M 73.31M 104.71M
Receivables 145.00K 145.00K 58.00K 79.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 44.09M 70.30M 80.28M 106.11M
Property, Plant & Equipment, Gross 3.15M 2.95M 3.92M 2.47M
Accumulated Depreciation & Depletion 2.62M 2.15M 1.92M 1.32M
Property, Plant & Equipment, Net 531.00K 801.00K 1.99M 1.14M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 619.00K 656.00K 1.13M 862.00K
Total Non-Current Assets 1.15M 1.46M 3.13M 2.00M
Liabilities & Shareholder Equity
Total Assets 45.24M 71.75M 83.40M 108.11M
Accounts Payable 2.00M 422.00K 1.51M 1.73M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 280.00K 212.00K 39.00K 263.00K
Total Current Liabilities 10.83M 7.79M 18.86M 13.36M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 570.00K 851.00K 400.00K 0.00
Other Non-Current Liabilities 0.00 13.73M 15.70M 23.14M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 570.00K 14.58M 16.09M 23.14M
Total Liabilities 11.40M 22.37M 34.96M 36.50M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 33.84M 49.38M 48.45M 71.61M
Common Par 104.00K 100.00K 83.00K 69.00K
Additional Paid In Capital 406.35M 390.11M 332.09M 259.13M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -372.61M -340.83M -283.72M -187.59M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 33.84M 49.38M 48.45M 71.61M
Total Equity 33.84M 49.38M 48.45M 71.61M
Total Liabilities & Stock Equity 45.24M 71.75M 83.40M 108.11M
Total Common Shares Outstanding 104.45M 100.16M 83.24M 69.21M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 101.13M 85.94M 78.55M 66.00M
Diluted Weighted Shares Outstanding 101.13M 85.94M 78.55M 66.00M
Number of Employees 27 43 83 66
Number of Part-Time Employees 0 0 0 0

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of ZIOP

Analysts Ratings for ZIOP

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy
Moderate Buy
Moderate Sell
Strong Sell

ZIOP Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs